Attached files

file filename
8-K - 8-K - Adeptus Health Inc.adpt-20150219x8k.htm

 

 

C:\Users\mvangb\Desktop\adeptus2.jpg

Exhibit 99.1

 

 

ADPT News - For Immediate Release

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ADEPTUS HEALTH REPORTS FOURTH QUARTER AND YEAR END RESULTS

Net Revenue Increased 108.0% for Fourth Quarter

Net Revenue Increased 104.8% for Full Year

29 New Facilities Opened during the year for a total of 55 Freestanding Facilities

 

Lewisville, Texas (February 19, 2015) — Adeptus Health Inc. (NYSE: ADPT) (“ADPT” or the “Company”), the largest operator of freestanding emergency rooms in the U.S., announced its results for the fourth quarter and full year ended December 31, 2014. All comparisons included in this release are for the same period in the prior year, unless otherwise noted.

 

Fourth Quarter 2014 Highlights:

 

                 Net revenue increased 108.0% to $70.1 million from $33.7 million in prior year;

 

                 Adjusted EBITDA increased 54.5% to $10.2 million from $6.6 million in prior year;

 

                 Net income attributable to Adeptus Health Inc. was $0.3 million;

 

                Adjusted earnings per share was $0.09 and GAAP earnings per share was $0.03;

 

 

                Patient volume (number of patient visits) increased 91.1%, to 47,643, over prior year; and

 

                The Company opened 4 freestanding facilities during the fourth quarter 2014 for a full year total of 55 operating facilities. 

  

Year End 2014 Highlights:

 

                 Net revenue increased 104.8% to $210.7 million from $102.9 million in prior year;

 

                 Adjusted EBITDA increased 76.1% to $28.2 million from $16.0 million in prior year;

 

                 Net loss attributable to Adeptus Health Inc. was $3.4 million;

 

                Adjusted earnings per share was $0.04 and GAAP net loss per share was $0.34;

 

                Patient volume (number of patient visits) increased 89.6%, to 146,058, over prior year; and

 

                The Company opened 29 freestanding facilities during 2014 for a total of 55 operating facilities.

 

2015 Guidance:

 

                 Systemwide net revenue of $367.0 million to $377.0 million; Adjusted EBITDA of $49.0 million to $53.0 million.

 

“2014 was a milestone year of expansion for Adeptus Health.  We added 29 new emergency rooms, more than doubling our number of freestanding facilities, built our first hospital and maintained our focus of delivering the highest quality care to the communities we serve.  Our patients rated our care among the top 1% in the nation, our team members voted us among the best companies to work for, and our partnership with an industry leader is expanding our model into new markets to enhance the continuum of care,” said Thomas S. Hall, Chairman, President and Chief Executive Officer.

 

 


 

Results of Operations for the Fourth Quarter 2014

 

For the fourth quarter of 2014, ADPT generated net revenue of $70.1 million, an increase of 108.0%. The increase was primarily attributable to the impact of increased patient volumes from the expansion of the number of freestanding facilities from 26 to 55.  This increase was negatively impacted by the Ebola virus in the DFW market during the fourth quarter 2014 compared to the same period in 2013.

 

Adjusted EBITDA increased 54.5% to $10.2 million.  This increase was primarily attributable to a $36.3 million increase in net revenue, partially offset by increases in salaries, wages and benefits and other costs related to our growth initiatives. See "Non-GAAP Financial Measures Description and Reconciliation" and "Reconciliation of Adjusted EBITDA to Net Loss" below for further information related to Adjusted EBITDA and its reconciliation to net loss.

 

ADPT incurred a net loss of $1.5 million for the quarter, of which $0.3 million of net income was attributable to Adeptus Health Inc., compared to a net loss of $2.0 million from the prior year. The decrease in net loss was due to an increase of $36.3 million in net revenue, partially offset by increases in salaries, wages and benefits and other costs related to our growth initiatives, including an increase in interest expense and fees of $1.2 million related to our long-term debt, an increase of $2.2 million in preopening costs associated with new facility openings, including $0.9 million related to its equity interest in Dignity Health Arizona General Hospital, and an increase of $2.1 million in depreciation and amortization expense.  

 

Adjusted earnings per share was $0.09 per share and GAAP earnings per share was $0.03 per share for the quarter.  Adjusted earnings per share is calculated using a weighted average of both Class A and Class B common shares outstanding, which was 20,626,169 common shares at December 31, 2014.  Adjustments for the quarter include $4.4 million of preopening costs associated with new facility openings, including Dignity Health Arizona General Hospital, $0.3 million of stock compensation expense, $0.4  million of other costs associated with our growth initiatives and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes.  See "Non-GAAP Financial Measures Description and Reconciliation" and "Earnings Per Share Reconciliation" below for further information related to Adjusted earnings per share and its reconciliation to net loss.

 

Results of Operations for the Year Ended 2014

 

For the year ended December 31, 2014, ADPT generated net revenue of $210.7 million, an increase of 104.8%. The increase was primarily attributable to the impact of increased patient volumes from the expansion of the number of freestanding facilities from 26 to 55

 

Adjusted EBITDA increased 76.1% to $28.2 million. This increase was primarily attributable to a $107.8 million increase in net revenue, partially offset by increases in salaries, wages and benefits and other costs related to our growth initiatives.  See "Non-GAAP Financial Measures Description and Reconciliation" and "Reconciliation of Adjusted EBITDA to Net Loss" below for further information related to Adjusted EBITDA and its reconciliation to net loss.

 

ADPT incurred a net loss of $17.3 million for the year ended December 31, 2014, of which $3.4 million was attributable to Adeptus Health Inc., compared to a net loss of $3.0 million from the prior year. The increase in net loss was due to an increase in interest expense and fees of $9.1 million related to our long-term debt, an increase of $6.6 million in preopening costs associated with new facility openings, an increase of $6.4 million related to our initial public offering and other public company costs, and an increase of $7.1 million in depreciation and amortization expense.  The increase in these expenditures was partially offset by new facility operating income.

 

Adjusted earnings per share was $0.04 per share and GAAP net loss per share was $0.34 per share for the year ended December 31, 2014.  Adjusted earnings per share is calculated using a weighted average of both Class A and Class B common shares outstanding, which was 20,626,169 common shares at December 31, 2014.  Adjustments for the year include $10.6 million of preopening costs associated with new facility openings, $1.0 million of stock compensation expense, $5.2 million of initial public offering costs, $8.3 million of other costs associated with our growth initiatives and an adjustment for taxes in order to establish a normalized tax rate of 35% for comparability purposes.  See "Non-GAAP Financial Measures Description and Reconciliation" and "Earnings Per Share Reconciliation" below for further information related to Adjusted earnings per share and its reconciliation to net loss.

 

At December 31, 2014, the Company had total long-term debt of $106.8 million.  Total availability under the debt facility was $84.2 million, contingent upon meeting its debt covenants

 

Market Outlook

 

In December 2014, the new partnership with Dignity Health became effective with Dignity Health Arizona General Hospital, a full service general hospital located in Laveen, Arizona.  In December, the facility began its training and certification phase of operation and received CMS certification from the Joint Commission on January 30, 2015. All activity related to this facility is deemed preopening and added back in the calculation of adjusted EBITDA and adjusted earnings per share prior to receiving CMS certification. 

 

ADPT continues to expand its freestanding emergency room network at an expected rate of opening 24 new sites per year.  During


 

January 2015, ADPT opened four new First Choice Emergency Rooms.  Additionally, ADPT began construction on its second new hospital in late 2014.  The hospital in Carrollton, Texas, a Dallas-Ft Worth suburb, is scheduled to open in late 2015.  The hospital will feature inpatient rooms, advanced operating suites, an emergency department, a high complexity laboratory and a full radiology suite and will be capable of inpatient and outpatient surgical procedures.  The new hospital will also provide Carrollton-area residents with 24/7 access to emergency medical care treating a broad spectrum of illnesses and injuries that require immediate medical attention.

 

ADPT sees strong opportunities for continued growth as it strives to play a leading role in meeting demand for increased access to quality medical care and improved emergency care in the U.S. In their 2014 National Report Card on America’s emergency care environment, the American College of Emergency Physicians, or ACEP, assigned an overall grade of “D-” for the category of access to emergency care. The poor grade reflects too few emergency departments to meet the needs of a growing, aging population and the projected increase in the number of insured individuals as a result of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, or PPACA.

 

We are literally helping to change the delivery of emergency medical care in America.  Our thesis remains the same, which is to bring access to the highest quality care to the communities we serve,” added Mr. Hall. 

 

2015 Guidance

 

Based on our strong 2014 performance and continued growth plans including 24 freestanding facilities and two new hospitals, we expect to generate systemwide net revenue, which includes revenue from our unconsolidated joint venture, of $367.0 million to $377.0 million for the full year 2015.  We expect Adjusted EBITDA of $49.0 million to $53.0 million for 2015. 

 

Conference Call

 

ADPT management will host a live conference call and audio webcast today, Thursday, February 19, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time), to discuss the Company’s fourth quarter and year end 2014 financial results. Participants may listen to the audio webcast by accessing http://www.videonewswire.com/event.asp?id=101526.  Participants are encouraged to link to the webcast at least fifteen minutes prior to the scheduled start time. Beginning one hour after the call, an archived recording of the webcast will be available on the Company’s Investor page at http://ir.adeptushealth.com/events-and-presentations/events/default.aspx and will be available for 30 days.

 

 

Media Contact:

Jackie Zupsic

Hill & Knowlton Strategies

Jackie.Zupsic@hkstrategies.com 

Tel: (212) 885 – 0590 

 

 

Investor Relations Contact:

Susan A. Noonan

S.A. Noonan Communications

susan@sanoonan.com 

Tel: (212) 966 – 3650 

 

About Adeptus Health Inc.

 

Adeptus Health Inc. owns and operates First Choice Emergency Room, and, together with Dignity Health, Dignity Health Arizona General Hospital.  First Choice Emergency Room (FCER.com) is the leading operator of independent freestanding emergency rooms in the U.S.; it is both the largest and the oldest. First Choice Emergency Room is revolutionizing the delivery of emergency medical services for adult and pediatric emergencies by offering patients convenient, neighborhood access to emergency medical care. First Choice Emergency Room facilities are innovative, freestanding, and fully equipped emergency rooms with a complete radiology suite of diagnostic technology (CT scanner, Ultrasound, and Digital X-ray) and on-site laboratory. All First Choice Emergency Room locations are staffed with board-certified physicians and emergency trained registered nurses. First Choice Emergency Room has facilities in Austin, Dallas/Fort Worth, Houston, San Antonio, Colorado Springs and Denver. According to patient feedback collected by Press Ganey Associates Inc., First Choice Emergency Room provides the highest quality emergency medical care and received the 2013 and 2014 Press Ganey Guardian of Excellence for exceeding the 95th percentile in patient satisfaction nationwide. Dignity Health Arizona General Hospital is a full service general hospital in the Phoenix area. Arizona General Hospital has 16 inpatient rooms, 2 state-of-the-art Operating Rooms, an Emergency Department, a high complexity laboratory, and a full radiology suite. The new hospital, located in Laveen, is capable of inpatient and outpatient surgical procedures as well as providing the community 24/7 access to emergency medical care.

 

Forward-Looking Statements

 

Certain statements and information herein may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating


 

to our guidance, objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.  Any forward-looking statements herein are made as of the date of this press release, and ADPT undertakes no duty to update or revise any such statements except as required by the federal securities laws. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in ADPT’s filings with the U.S. Securities and Exchange Commission (“SEC”) from time to time and which are accessible on the SEC’s website at www.sec.gov, including in the section entitled “Risk Factors” in the Company’s prospectus dated June 24, 2014, filed with the SEC pursuant to Rule 424(b) of the Securities Act on June 25, 2014. Among the factors that could cause future results to differ materially from those provided in this press release are: our ability to implement our growth strategy; our ability to maintain sufficient levels of cash flow to meet growth expectations; our ability to protect our brand; federal and state laws and regulations relating to our facilities, which could lead to the incurrence of significant penalties by us or require us to make significant changes to our operations; our ability to locate available facility sites on terms acceptable to us; competition from hospitals, clinics and other emergency care providers; our dependence on payments from third-party payors; our ability to source and procure new products and equipment to meet patient preferences; our reliance on Medical Properties Trust (“MPT”) and the MPT Master Funding and Development Agreement; disruptions in the global financial markets leading to difficulty in borrowing sufficient amounts of capital to finance the carrying costs of inventory to pay for capital expenditures and operating costs; our ability or the ability of our healthcare system partners to negotiate favorable contracts or renew existing contracts with third-party payors on favorable terms; significant changes in our payor mix or case mix resulting from fluctuations in the types of cases treated at our facilities; material changes in IRS revenue rulings, case law or the interpretation of such rulings; shortages of, or quality control issues with, emergency care-related products, equipment and medical supplies that could result in a disruption of our operations; the intense competition we face for patients, physician use of our facilities, strategic relationships and commercial payor contracts; the fact that we are subject to significant malpractice and related legal claims; the growth of patient receivables or the deterioration in the ability to collect on those accounts; the impact on us of PPACA, which represents a significant change to the healthcare industry; and ensuring our continued compliance with HIPAA, which could require us to expend significant resources and capital; and the factors discussed in the section entitled “Risk Factors” in the Company’s prospectus dated June 24, 2014, filed with the SEC pursuant to Rule 424(b) of the Securities Act on June 25, 2014.

These forward-looking statements involve known and unknown risks, inherent uncertainties and other factors, which may cause our actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. Actual results and the timing of certain events may differ materially from those contained in these forward-looking statements.

 

Non-GAAP Financial Measures Description and Reconciliation

 

This press release includes presentations of Adjusted EBITDA, which is defined as net income before interest, taxes, depreciation and amortization, further adjusted to eliminate the impact of certain additional items, including, advisory services paid to our Sponsor, facility pre-opening expenses, management recruiting expenses, stock compensation expense, costs associated with our initial public offering and other non-recurring costs.

 

This press release also includes presentation of Adjusted earnings/loss per share, which is defined as earnings/loss per share related to the Company’s overall operation, including controlling and non-controlling interests, as adjusted to exclude certain additional items, including, advisory services paid to our Sponsor, facility preopening expenses, management recruiting expenses, stock compensation expense, costs associated with our initial public offering and other non-recurring costs, divided by the aggregate number of shares of Class A and Class B common stock outstanding as of the end of the period. Common stock calculations are treated as if the stock had been outstanding for the entire period.

 

These non-GAAP financial measures, Adjusted EBITDA and Adjusted earnings/loss per share, are commonly used by management and investors as performance measures. The Company’s non-GAAP financial measures are not considered measures of financial performance under U.S. generally accepted accounting principles (GAAP), and the items excluded therefrom are significant components in understanding and assessing our financial performance. These non-GAAP financial measures should not be considered in isolation or as an alternative to GAAP measures such as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance. Reconciliations of non-GAAP financial measures are provided in this press release.  Since these non-GAAP financial measures are not measures determined in accordance with GAAP and are susceptible to varying calculations, these measures, as presented, may not be comparable to other similarly titled measures of other companies.

 


 

Adeptus Health Inc.

Consolidated Statements of Operations and Other Information

(unaudited; in thousands, except shares, per share data and other information)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended December 31,

 

Year ended December 31,

 

    

2014

    

2013

    

2014

    

2013

Patient service revenue

 

$

80,290 

 

$

38,885 

 

$

243,298 

 

$

114,960 

Provision for bad debt

 

 

(10,234)

 

 

(5,173)

 

 

(32,624)

 

 

(12,077)

Net patient service revenue

 

 

70,056 

 

 

33,712 

 

 

210,674 

 

 

102,883 

Management and contract services revenue

 

 

20 

 

 

 -

 

 

20 

 

 

 -

Total net operating revenue

 

 

70,076 

 

 

33,712 

 

 

210,694 

 

 

102,883 

Equity in net loss of unconsolidated joint venture

 

 

(900)

 

 

 -

 

 

(900)

 

 

 -

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Salaries, wages and benefits

 

 

43,921 

 

 

20,618 

 

 

136,498 

 

 

65,244 

General and administrative

 

 

10,860 

 

 

6,297 

 

 

37,604 

 

 

17,436 

Other operating expenses

 

 

9,916 

 

 

3,748 

 

 

27,329 

 

 

11,185 

(Gain) loss from the disposal or impairment of assets

 

 

(45)

 

 

27 

 

 

(42)

 

 

207 

Depreciation and amortization

 

 

4,663 

 

 

2,518 

 

 

15,037 

 

 

7,920 

Total operating expenses

 

 

69,315 

 

 

33,208 

 

 

216,426 

 

 

101,992 

(Loss) income from operations

 

 

(139)

 

 

504 

 

 

(6,632)

 

 

891 

Other (expense) income:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(2,806)

 

 

(1,614)

 

 

(11,966)

 

 

(2,827)

Change in fair market value of derivatives

 

 

 -

 

 

(148)

 

 

 -

 

 

112 

Write-off of deferred loan costs

 

 

 -

 

 

(440)

 

 

 -

 

 

(440)

Total other (expenses) income

 

 

(2,806)

 

 

(2,202)

 

 

(11,966)

 

 

(3,155)

Loss before (benefit) provision for income taxes

 

 

(2,945)

 

 

(1,698)

 

 

(18,598)

 

 

(2,264)

(Benefit) provision for income taxes

 

 

(1,468)

 

 

276 

 

 

(1,326)

 

 

720 

Net loss

 

 

(1,477)

 

 

(1,974)

 

 

(17,272)

 

 

(2,984)

Less: Net loss attributable to the non-controlling interest

 

 

(1,739)

 

 

(1,974)

 

 

(13,921)

 

 

(2,984)

Net income (loss) attributable to Adeptus Health Inc. 

 

$

262 

 

$

 -

 

$

(3,351)

 

$

 -

Net income (loss) per share of Class A common stock:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.03 

 

 

 -

 

$

(0.34)

 

 

 -

Diluted

 

$

0.03 

 

 

 -

 

$

(0.34)

 

 

 -

Weighted average shares of Class A common stock:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

9,845,016 

 

 

 -

 

 

9,845,016 

 

 

 -

Diluted

 

 

9,845,016 

 

 

 -

 

 

9,845,016 

 

 

 -

 

 

 

 

 

 

 

 

 

 

 

 

 

Other information

 

 

 

 

 

 

 

 

 

 

 

 

Number of facilities

 

 

55 

 

 

26 

 

 

55 

 

 

26 

 


 

Adeptus Health Inc.

Reconciliation of Adjusted EBITDA to Net Loss

(unaudited; in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

Year ended

 

 

December 31,

 

December 31,

 

    

2014

    

2013

    

2014

    

2013

Net loss

 

$

(1,477)

 

$

(1,974)

 

$

(17,272)

 

$

(2,984)

Depreciation and amortization

 

 

4,663 

 

 

2,518 

 

 

15,037 

 

 

7,920 

Interest expense and unrealized gain on investment

 

 

2,806 

 

 

2,202 

 

 

11,966 

 

 

3,155 

(Benefit) provision for income taxes

 

 

(1,468)

 

 

276 

 

 

(1,326)

 

 

720 

Advisory services arrangement fees and expenses

 

 

 -

 

 

131 

 

 

293 

 

 

559 

Preopening expenses

 

 

4,443 

 

 

2,217 

 

 

10,550 

 

 

3,977 

Management recruiting expenses

 

 

220 

 

 

433 

 

 

376 

 

 

719 

Stock compensation expense

 

 

319 

 

 

191 

 

 

1,015 

 

 

586 

Public offering expenses

 

 

 -

 

 

 -

 

 

5,157 

 

 

 -

Other

 

 

657 

 

 

613 

 

 

2,404 

 

 

1,358 

Total adjustments

 

 

11,640 

 

 

8,581 

 

 

45,472 

 

 

18,994 

Adjusted EBITDA

 

$

10,163 

 

$

6,607 

 

$

28,200 

 

$

16,010 

 

 

 

 

Earnings Per Share Reconciliation

 (unaudited; in thousands, except shares, per share data and other information)

 

 

 

 

 

 

 

 

 

 

 

 

    

Three months ended

    

Year ended

 

 

 

December 31,

 

 

December 31,

 

    

2014

    

2014

Weighted average common shares outstanding

 

 

 

 

 

 

Class A common shares (1)

 

 

9,845,016 

 

 

9,845,016 

Class B common shares (1)

 

 

10,781,153 

 

 

10,781,153 

Total Class A and B common shares

 

 

20,626,169 

 

 

20,626,169 

 

 

 

 

 

 

 

Net income (loss) attributable to Adeptus Health Inc.

 

$

262 

 

$

(3,351)

Net loss attributable to non-controlling interest

 

 

(1,739)

 

 

(13,921)

Total net loss

 

 

(1,477)

 

 

(17,272)

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

Advisory Services Agreement fees and expenses

 

 

 -

 

 

293 

Preopening expenses

 

 

4,443 

 

 

10,550 

Management recruiting expenses

 

 

220 

 

 

376 

Stock compensation expense

 

 

319 

 

 

1,015 

Initial public offering costs

 

 

 -

 

 

5,157 

Other

 

 

657 

 

 

2,404 

Total adjustments

 

 

5,639 

 

 

19,795 

Tax impact of adjustments (2)

 

 

(1,974)

 

 

(6,928)

Tax adjustment resulting from applying effective tax rate (3)

 

 

(437)

 

 

5,183 

Adjusted net income

 

 

1,751 

 

 

778 

Adjusted net income per share

 

$

0.09 

 

$

0.04 

 

 

 

 

 

 

 

(1) Due to the timing of our initial public offering, this calculation assumes that common shares have been outstanding for the entire period.

(2) Reflects the removal of the tax benefit associated with the adjustments

(3) Represents adjusting to a normalized effective tax rate of 35%

 


 

Adeptus Health Inc.

Condensed Consolidated Balance Sheets

(unaudited; in thousands)

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

December 31,

 

    

2014

    

2013

ASSETS

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$

2,002 

 

$

11,495 

Restricted cash

 

 

4,795 

 

 

294 

Accounts receivable, less allowance for doubtful accounts of $13,068 and $5,295, respectively

 

 

37,422 

 

 

15,887 

Other receivables and current assets

 

 

17,137 

 

 

3,901 

Medical supplies inventory

 

 

4,287 

 

 

1,494 

Total current assets

 

 

65,643 

 

 

33,071 

Property and equipment, net

 

 

93,892 

 

 

62,087 

Investment in unconsolidated joint venture

 

 

2,100 

 

 

 -

Deposits

 

 

1,772 

 

 

750 

Deferred tax asset

 

 

34,084 

 

 

 -

Intangibles, net

 

 

20,015 

 

 

21,795 

Goodwill

 

 

61,009 

 

 

61,009 

Other long term assets

 

 

4,303 

 

 

4,580 

Total assets

 

$

282,818 

 

$

183,292 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS'/OWNERS' EQUITY

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

25,420 

 

$

15,207 

Accrued compensation

 

 

13,521 

 

 

9,158 

Current maturities of long-term debt

 

 

1,191 

 

 

504 

Current maturities of capital lease obligations

 

 

81 

 

 

58 

Deferred rent

 

 

607 

 

 

497 

Total current liabilities

 

 

40,820 

 

 

25,424 

Long-term debt, less current maturities

 

 

105,607 

 

 

75,000 

Payable to related parties pursuant to tax receivable agreement

 

 

30,039 

 

 

 -

Capital lease obligation, less current maturities

 

 

4,056 

 

 

3,849 

Deferred rent

 

 

2,416 

 

 

368 

Total liabilities

 

 

182,938 

 

 

104,641 

Commitments and contingencies

 

 

 

 

 

 

Shareholders'/Owners' equity

 

 

 

 

 

 

Owners' equity

 

 

 -

 

 

78,651 

Preferred stock, par value $0.01 per share; 10,000,000 shares authorized and zero shares issued and outstanding at December 31, 2014

 

 

 -

 

 

 -

Class A common stock, par value $0.01 per share; 50,000,000 shares authorized, 9,845,016 shares issued and outstanding at December 31, 2014

 

 

98 

 

 

 -

Class B common stock, par value $0.01 per share; 20,000,000 shares authorized 10,781,153 shares issued and outstanding at December 31, 2014

 

 

108 

 

 

 -

Additional paid in capital

 

 

51,238 

 

 

 -

Accumulated other comprehensive loss

 

 

(74)

 

 

 -

Accumulated deficit

 

 

(3,351)

 

 

 -

Non-controlling interest

 

 

51,861 

 

 

 -

Total shareholders'/owners' equity

 

 

99,880 

 

 

78,651 

Total liabilities and shareholders'/owners' equity

 

$

282,818 

 

$

183,292 

 


 

Adeptus Health Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited; in thousands)

 

 

 

 

 

 

 

 

 

 

 

Year ended

 

 

December 31,

 

 

2014

 

2013

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(17,272)

 

$

(2,984)

Adjustments to reconcile net loss to net cash (used in) provided by operating activities:

 

 

 

 

 

 

Loss from the disposal or impairment of assets

 

 

(42)

 

 

207 

Change in fair market value of derivatives

 

 

 -

 

 

(112)

Depreciation and amortization

 

 

15,037 

 

 

7,920 

Deferred tax benefit

 

 

(2,147)

 

 

 -

Amortization of deferred loan costs

 

 

891 

 

 

293 

Provision for bad debts

 

 

32,624 

 

 

12,077 

Write-off of deferred loan costs

 

 

 -

 

 

440 

Equity in loss of unconsolidated joint venture

 

 

900 

 

 

 -

Stock-based compensation

 

 

1,015 

 

 

586 

Changes in operating assets and liabilities

 

 

 

 

 

 

Restricted cash

 

 

(4,501)

 

 

(294)

Accounts receivable

 

 

(54,159)

 

 

(18,107)

Other receivables and current assets

 

 

(8,248)

 

 

(1,757)

Medical supplies inventory

 

 

(2,793)

 

 

(850)

Other long-term assets

 

 

63 

 

 

(79)

Accounts payable and accrued expenses

 

 

7,413 

 

 

5,632 

Accrued compensation

 

 

4,363 

 

 

3,883 

Deferred rent

 

 

2,158 

 

 

17 

Net cash (used in) provided by operating activities

 

 

(24,698)

 

 

6,872 

Cash flows from investing activities:

 

 

 

 

 

 

Investment in unconsolidated joint venture

 

 

(3,000)

 

 

 -

Deposits

 

 

(1,022)

 

 

(413)

Proceeds from the sale of property and equipment

 

 

2,003 

 

 

1,814 

Capital expenditures

 

 

(47,429)

 

 

(46,048)

Net cash used in investing activities

 

 

(49,448)

 

 

(44,647)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from initial public offering, net of underwriters fees and expenses

 

 

96,226 

 

 

 -

Proceeds from long-term borrowings

 

 

99,457 

 

 

102,000 

Payment of deferred loan costs

 

 

(751)

 

 

(4,954)

Payments on borrowings

 

 

(70,380)

 

 

(50,855)

Payments of capital lease obligations

 

 

(57)

 

 

(5)

Payment of dividends

 

 

(60,000)

 

 

(421)

Distributions to partners

 

 

(9)

 

 

(33)

Contribution from partners

 

 

167 

 

 

83 

Net cash provided by financing activities

 

 

64,653 

 

 

45,815 

Net (decrease) increase in cash

 

 

(9,493)

 

 

8,040 

Cash, beginning of period

 

 

11,495 

 

 

3,455 

Cash, end of period

 

$

2,002 

 

$

11,495